Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 20 (4), 563-572

Sarcopenia in Gastric Cancer: When the Loss Costs Too Much

Affiliations
Review

Sarcopenia in Gastric Cancer: When the Loss Costs Too Much

Elena Ongaro et al. Gastric Cancer.

Abstract

Sarcopenia is a complex syndrome characterized by progressive and generalized loss of skeletal muscle mass and strength. Malignancy is a major determinant of sarcopenia, and gastric cancer (GC) is among the most common causes of this phenomenon. As sarcopenia is a well-recognized poor prognostic feature in GC and has been associated with worse tolerance of surgical and medical treatments, members of the multidisciplinary team should be aware of the clinical relevance, pathogenic mechanisms, and potential treatments for this syndrome. The importance of sarcopenia is often underestimated in everyday practice and clinical trials, particularly among elderly or fragile patients. As treatment options are improving in all disease stages, deeper knowledge and greater attention to the metabolic balance in GC patients could further increase the benefit of novel therapeutic strategies and dramatically impact on quality of life. In this review, we describe the role of sarcopenia in different phases of GC progression. Our aim is to provide oncologists and surgeons dealing with GC patients with a useful tool for comprehensive assessment and timely management of this potentially life-threatening condition.

Keywords: Gastric cancer; Malnutrition; Nutritional assessment; Sarcopenia; Weight loss.

Similar articles

See all similar articles

Cited by 5 articles

References

    1. Br J Nutr. 2005 Apr;93(4):509-13 - PubMed
    1. Anticancer Res. 2012 May;32(5):2111-8 - PubMed
    1. Am J Med. 1980 Oct;69(4):491-7 - PubMed
    1. Clin Nutr. 2007 Dec;26(6):667-76 - PubMed
    1. Eur J Cancer. 1998 Mar;34(4):503-9 - PubMed

LinkOut - more resources

Feedback